Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer
1350.3000 1.90 (0.14%)
NSE Sep 25, 2025 10:56 AM
Volume: 42,788
 

1350.30
0.14%
Phillip Capital
that focused mainly on the malaria division. Thus, it expects improved operating efficiency from Q4, led by enhanced productivity and better revenue mix in the domesticmarket.SeesimprovingUSsalessupportingprofitability....
Ipca Laboratories Ltd.'s price crossed below 30Day SMA today
More from Ipca Laboratories Ltd.
Recommended